Atlas Trials

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

Clinical trial NCT01979523 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01979523
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Start date
2013-11-21
Primary completion
2017-09-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.